Questioning the Relevance of Normal White Blood Cell Count under 10,000 Cells per Microlitre in Millard Criteria as an Absolutely Required Parameter for Cleft Lip Repair Surgeries: A Case-Based Literature Review
Main Article Content
Abstract
Leukocytosis, defined as an elevated white blood cell count, has long been regarded as a crucial indicator of inflammation or infection in surgical procedures. In the context of cleft lip surgeries, normal white blood cell count has often been considered an absolute requirement for proceeding with the procedure, as it is believed to signal the presence of a potentially infectious or inflammatory state. Therefore, leukocytosis is thought to be a strong precautionary factor. However, recent evidence challenges this long-held belief, suggesting that elevated white blood cell counts may not necessarily be indicative of adverse outcomes in cleft lip surgeries. To explore this notion, we conducted a comprehensive literature review focusing on two case studies involving unilateral cleft lip patients with presurgical white blood cell counts exceeding 10,000 per microlitre. Both cases underwent successful cleft lip repair and demonstrated excellent post-surgical outcomes without any signs of inflammation or infection. Both cleft lip repair surgeries results showed no complications, and the patient exhibited optimal wound healing and an aesthetically pleasing outcome at the follow-up appointments. These cases challenge the assumption that normal white blood cell count is an absolute requirement for cleft lip surgeries and call for a reconsideration of its significance in predicting post-surgical outcomes. While leukocytosis is an essential parameter to identify potential infectious or inflammatory states, our findings suggest that it should not be solely relied upon in isolation when assessing the suitability for cleft lip surgery and predicting the adverse outcomes in cleft lip surgeries. Further studies are warranted to establish a more nuanced understanding of leukocytosis in the context of cleft lip surgeries, including its association with other clinical parameters and potential alternatives for evaluating surgical candidacy and predicting the adverse outcomes in cleft lip surgeries.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Riley LK, Rupert J. Evaluation of patients with leukocytosis. Am Fam Physician. 2015 Dec 1;92(11):1004–11.
II. Cruz Shibukawa BM, Rissi GP, Higarashi IH, De Oliveira RR. Factors associated with the presence of cleft lip and/or cleft palate in Brazilian newborns. Revista Brasileira de Saude Materno Infantil. 2019 Sep 1;19(4):947–56.
III. Ramzy Sayed M, Taha Sayed A, Mohammed Ali M. Unilateral cleft lip repair: A comparison of treatment outcome with two operative methods. Al-Azhar Medical Journal. 2023 Apr 1;52(2):763–76.
IV. Shkoukani MA, Chen M, Vong A. Cleft lip - A comprehensive review. Vol. 1, Frontiers in Pediatrics. Frontiers Media S.A.; 2013.
V. Wilhelmsen HR, Musgrave RH. Complications of cleft lip surgery. Cleft Palate J. 1966 Jul;3:223-31.
VI. Millard RD. (1976). Cleft craft. The evolution of its surgery: The unilateral deformity (1st ed.). Boston: Little Brown. pp. 69–74.
VII. American Cleft Palate Craniofacial Association (2004). Core curriculum for cleft lip/palate and other craniofacial anomalies: a guide for educators.
VIII. Chow I, Purnell CA, Hanwright PJ, Gosain AK. Evaluating the Rule of 10s in Cleft Lip Repair: Do Data Support Dogma? Plast Reconstr Surg. 2016 Sep;138(3):670-679.
doi: 10.1097/PRS.0000000000002476.
IX. Watted A, Watted N, Abu-Hussein M. Multidisciplinary Treatment in Cleft Lip and Palate Patients. International Journal of Dental Research and Oral Health. 2020 Jul 7;2(1).
X. Haider SM, Latif W. Oral & Maxillofacial Surgery; A historical review of the development of the surgical discipline. Vol. 55, International Journal of Surgery. Elsevier Ltd; 2018. p. 224–6.
XI. Okolie PN, Saheeb BD, Obuekwe ON, Edetanlen EB. Effects of Surgical Trauma on Peripheral White Blood Cell Count Following Major Oral and Maxillofacial Surgical Procedures. Vol. 35, African Journal of Health Sciences. 2022.
XII. Bain BJ. Structure and function of red and white blood cells. Vol. 45, Medicine (United Kingdom). Elsevier Ltd; 2017. p. 187–93.
https://doi.org/10.1016/j.mpmed.2017.01.011.
XIII. Hammoudeh JA, Imahiyerobo TA, Liang F, Fahradyan A, Urbinelli L, Lau J, Matar M, Magee W 3rd, Urata M. Early Cleft Lip Repair Revisited: A Safe and Effective Approach Utilizing a Multidisciplinary Protocol. Plast Reconstr Surg Glob Open. 2017 Jun 26;5(6):e1340.
doi: 10.1097/GOX.0000000000001340.
XIV. Moghadamyeghaneh Z, Hanna MH, Carmichael JC, Mills SD, Pigazzi A, Stamos MJ. Preoperative Leukocytosis in Colorectal Cancer Patients. J Am Coll Surg. 2015 Jul;221(1):207-14. doi: 10.1016/j.jamcollsurg.2015.03.044.
XV. Adeli K, Raizman JE, Chen Y, Higgins V, Nieuwesteeg M, Abdelhaleem M, Wong SL, Blais D. Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. Clin Chem. 2015 Aug;61(8):1075-86. doi: 10.1373/clinchem.2015.240531.
XVI. CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, Third Edition. CLSI document EP28-A3c. Wayne, PA, Clinical and Laboratory Standards Institute, 2008
XVII. Soldin J, Brugnara C, Wong EC: Pediatric Reference Intervals. Fifth Edition. AACC Press. Washington, DC, 2005. ISBN 1-594250-32-4.
XVIII. Mayo Clinic Lab Team. Mayo Clinic Laboratories: Pediatric Catalog Powered by Mayo Clinic Laboratories. Mayo Clinic Laboratories | Pediatric Catalog. https://pediatric.testcatalog.org/show/CBC.
XIX. Rosenfeld-Yehoshua N, Barkan S, Abu-Kishk I, Booch M, Suhami R, Kozer E. Hyperpyrexia and high fever as a predictor for serious bacterial infection (SBI) in children-a systematic review. Eur J Pediatr. 2018 Mar;177(3):337-344. doi: 10.1007/s00431-018-3098-x. Epub 2018 Jan 31. Erratum in: Eur J Pediatr. 2020 Feb;179(2):353.
XX. Wildes DM, Chisale M, Drew RJ, Harrington P, Watson CJ, Ledwidge MT, Gallagher J. A Systematic Review of Clinical Prediction Rules to Predict Hospitalisation in Children with Lower Respiratory Infection in Primary Care and their Validation in a New Cohort. EClinicalMedicine. 2021 Oct 18;41:101164. doi: 10.1016/j.eclinm.2021.101164.
XXI. Omoruyi EA. Practice Guideline: Approach to the Child with Rhinorrhea. J Pediatr Health Care. 2018 May-Jun;32(3):319-322.
doi: 10.1016/j.pedhc.2018.01.006.
XXII. Kato M, Watanabe A, Watanabe S, Utsunomiya H, Yokoyama T, Ogishima S. Cleft Lip and Palate Repair Using a Surgical Microscope. Arch Plast Surg. 2017 Nov;44(6):490-495.
doi: 10.5999/aps.2017.01060. Epub 2017 Oct 26.
XXIII. Abramson N, Melton B. Leukocytosis: basics of clinical assessment. Am Fam Physician. 2000 Nov 1;62(9):2053-60.
XXIV. Riley LK, Rupert J. Evaluation of Patients with Leukocytosis. Am Fam Physician. 2015 Dec 1;92(11):1004-11.
XXV. Dale DC, Fauci AS, Guerry D IV, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest. 1975 Oct;56(4):808-13. doi: 10.1172/JCI108159.
XXVI. Nakagawa M, Terashima T, D'yachkova Y, Bondy GP, Hogg JC, van Eeden SF. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation. 1998 Nov 24;98(21):2307-13.
doi: 10.1161/01.cir.98.21.2307.
XXVII. Shopsin B, Friedmann R, Gershon S. Lithium and leukocytosis. Clin Pharmacol Ther. 1971 Nov-Dec;12(6):923-8. doi: 10.1002/cpt1971126923.
XXVIII. Faria SS, Fernandes PC Jr, Silva MJ, Lima VC, Fontes W, Freitas-Junior R, Eterovic AK, Forget P. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience. 2016 Dec 12;10:702. doi: 10.3332/ecancer.2016.702.